RE: MTBE misclassified

Dr. Mehlman's commentary on the decision not to list methyl‐tertiary butyl ether (MTBE) in the NTP 9th Report on Carcinogens correctly raises process questions, but also leads back to the public health fundamentals of motor fuel toxicity. I was a voter in the minority for listing MTBE, and also...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of industrial medicine 2001-05, Vol.39 (5), p.509-510
1. Verfasser: Mirer, Franklin E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 510
container_issue 5
container_start_page 509
container_title American journal of industrial medicine
container_volume 39
creator Mirer, Franklin E.
description Dr. Mehlman's commentary on the decision not to list methyl‐tertiary butyl ether (MTBE) in the NTP 9th Report on Carcinogens correctly raises process questions, but also leads back to the public health fundamentals of motor fuel toxicity. I was a voter in the minority for listing MTBE, and also a peer reviewer for the revised criteria for listing substances some years ago. Dr. Mehlman's commentary brings to light a prime example of "Houdini Risk Assessments", risk assessments which make the risk disappear and, therefore, allow industry to escape preventive measures.
doi_str_mv 10.1002/ajim.1045
format Article
fullrecord <record><control><sourceid>istex_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1002_ajim_1045</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ark_67375_WNG_D6VG191H_D</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3595-3745d6ddfd4fdb8a6d51827b2b13297df684124bceecebf80902290d3aa1a913</originalsourceid><addsrcrecordid>eNp1jztPwzAYRS0EoqUwsDCirgyh_vyM2foIbVELEopgtJzYllwaUcUg6L8nUSqYmO4dzr3SQegS8C1gTEZmE6qmMX6E-oCVTDCR7Bj1m4CE8lT00FmMG4wBmGCnqAdAKWVA--jqObsbrvNJNqxCLLcmxuCDs-foxJttdBeHHKD8Psuni2T1NF9Ox6ukpFzxhErGrbDWW-ZtkRphOaREFqQASpS0XqQMCCtK50pX-BQrTIjClhoDRgEdoJvutqzfY6yd17s6VKbea8C6VdOtmm7VGva6Y3efReXsH3lwaYBRB3yFrdv__6THD8v14TLpFiF-uO_fhanftJBUcv36ONcz8TIHBQs9oz-ja2Tx</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>RE: MTBE misclassified</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Mirer, Franklin E.</creator><creatorcontrib>Mirer, Franklin E.</creatorcontrib><description>Dr. Mehlman's commentary on the decision not to list methyl‐tertiary butyl ether (MTBE) in the NTP 9th Report on Carcinogens correctly raises process questions, but also leads back to the public health fundamentals of motor fuel toxicity. I was a voter in the minority for listing MTBE, and also a peer reviewer for the revised criteria for listing substances some years ago. Dr. Mehlman's commentary brings to light a prime example of "Houdini Risk Assessments", risk assessments which make the risk disappear and, therefore, allow industry to escape preventive measures.</description><identifier>ISSN: 0271-3586</identifier><identifier>EISSN: 1097-0274</identifier><identifier>DOI: 10.1002/ajim.1045</identifier><identifier>PMID: 11333413</identifier><language>eng</language><publisher>New York: John Wiley &amp; Sons, Inc</publisher><subject>Carcinogens ; Environmental Exposure ; Gasoline ; Humans ; Methyl Ethers - pharmacology</subject><ispartof>American journal of industrial medicine, 2001-05, Vol.39 (5), p.509-510</ispartof><rights>Copyright © 2001 Wiley‐Liss, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3595-3745d6ddfd4fdb8a6d51827b2b13297df684124bceecebf80902290d3aa1a913</citedby><cites>FETCH-LOGICAL-c3595-3745d6ddfd4fdb8a6d51827b2b13297df684124bceecebf80902290d3aa1a913</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fajim.1045$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fajim.1045$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11333413$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mirer, Franklin E.</creatorcontrib><title>RE: MTBE misclassified</title><title>American journal of industrial medicine</title><addtitle>Am. J. Ind. Med</addtitle><description>Dr. Mehlman's commentary on the decision not to list methyl‐tertiary butyl ether (MTBE) in the NTP 9th Report on Carcinogens correctly raises process questions, but also leads back to the public health fundamentals of motor fuel toxicity. I was a voter in the minority for listing MTBE, and also a peer reviewer for the revised criteria for listing substances some years ago. Dr. Mehlman's commentary brings to light a prime example of "Houdini Risk Assessments", risk assessments which make the risk disappear and, therefore, allow industry to escape preventive measures.</description><subject>Carcinogens</subject><subject>Environmental Exposure</subject><subject>Gasoline</subject><subject>Humans</subject><subject>Methyl Ethers - pharmacology</subject><issn>0271-3586</issn><issn>1097-0274</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1jztPwzAYRS0EoqUwsDCirgyh_vyM2foIbVELEopgtJzYllwaUcUg6L8nUSqYmO4dzr3SQegS8C1gTEZmE6qmMX6E-oCVTDCR7Bj1m4CE8lT00FmMG4wBmGCnqAdAKWVA--jqObsbrvNJNqxCLLcmxuCDs-foxJttdBeHHKD8Psuni2T1NF9Ox6ukpFzxhErGrbDWW-ZtkRphOaREFqQASpS0XqQMCCtK50pX-BQrTIjClhoDRgEdoJvutqzfY6yd17s6VKbea8C6VdOtmm7VGva6Y3efReXsH3lwaYBRB3yFrdv__6THD8v14TLpFiF-uO_fhanftJBUcv36ONcz8TIHBQs9oz-ja2Tx</recordid><startdate>200105</startdate><enddate>200105</enddate><creator>Mirer, Franklin E.</creator><general>John Wiley &amp; Sons, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>200105</creationdate><title>RE: MTBE misclassified</title><author>Mirer, Franklin E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3595-3745d6ddfd4fdb8a6d51827b2b13297df684124bceecebf80902290d3aa1a913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Carcinogens</topic><topic>Environmental Exposure</topic><topic>Gasoline</topic><topic>Humans</topic><topic>Methyl Ethers - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mirer, Franklin E.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>American journal of industrial medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mirer, Franklin E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>RE: MTBE misclassified</atitle><jtitle>American journal of industrial medicine</jtitle><addtitle>Am. J. Ind. Med</addtitle><date>2001-05</date><risdate>2001</risdate><volume>39</volume><issue>5</issue><spage>509</spage><epage>510</epage><pages>509-510</pages><issn>0271-3586</issn><eissn>1097-0274</eissn><abstract>Dr. Mehlman's commentary on the decision not to list methyl‐tertiary butyl ether (MTBE) in the NTP 9th Report on Carcinogens correctly raises process questions, but also leads back to the public health fundamentals of motor fuel toxicity. I was a voter in the minority for listing MTBE, and also a peer reviewer for the revised criteria for listing substances some years ago. Dr. Mehlman's commentary brings to light a prime example of "Houdini Risk Assessments", risk assessments which make the risk disappear and, therefore, allow industry to escape preventive measures.</abstract><cop>New York</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>11333413</pmid><doi>10.1002/ajim.1045</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0271-3586
ispartof American journal of industrial medicine, 2001-05, Vol.39 (5), p.509-510
issn 0271-3586
1097-0274
language eng
recordid cdi_crossref_primary_10_1002_ajim_1045
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Carcinogens
Environmental Exposure
Gasoline
Humans
Methyl Ethers - pharmacology
title RE: MTBE misclassified
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T03%3A01%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-istex_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=RE:%20MTBE%20misclassified&rft.jtitle=American%20journal%20of%20industrial%20medicine&rft.au=Mirer,%20Franklin%20E.&rft.date=2001-05&rft.volume=39&rft.issue=5&rft.spage=509&rft.epage=510&rft.pages=509-510&rft.issn=0271-3586&rft.eissn=1097-0274&rft_id=info:doi/10.1002/ajim.1045&rft_dat=%3Cistex_cross%3Eark_67375_WNG_D6VG191H_D%3C/istex_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/11333413&rfr_iscdi=true